Strontium Ranelate Catalog No.:M9951-2 AIG1 and ADTRP are atypical

AIG1 and ADTRP are atypical integral membrane hydrolases that degrade bioactive FAHFAs

5-dimethoxybenzeneacetamide

CAS Number: 1431612-23-5

consistent with an inhibition of both mTORC1 and mTORC2 complexes

Effect of some brain stimulants

Strontium Ranelate Catalog No.:M9951-2 AIG1 and ADTRP are atypicalStrontium Ranelate is a strontium(II) salt of ranelic acid, is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA). The use is now restricted to treatment of severe osteoporosis in postmenopausal women